Physician

George H Godwin, M.D., F.A.C.S.

According to 2025 Medicare claims, George Godwin, M.D., F.A.C.S. (NPI: 1558342931) practices otolaryngology in the Decatur, AL market, with the plurality of this provider's patient population coming from Morgan, AL. This provider's primary affiliated billing organization is DECATUR ENT ASSOCIATES P C (NPI: 1164487708; TIN: 63-1027168) and primary practice location at 35601-4307.

Godwin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 592 traditional Medicare patients, billed 5,460 HCPCS/CPT codes, and received $121,460 in Medicare payments. The top billing code was 92584 (Test to assess electrical potentials generated in the inner ear as a result of sound stimulation). Part D data shows 1,269 prescription claims across 397 beneficiaries totaling $112,978 in drug costs, led by Nucala (Mepolizumab). 2023 DME data shows 19 claims. Open Payments data shows 9 records totaling $319. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $30,463 to $112,978. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	683	4,192	$146,853
2016	717	5,190	$152,393
2017	633	4,640	$134,671
2018	647	6,052	$174,835
2019	679	5,056	$156,007
2020	505	4,548	$143,975
2021	589	4,308	$138,993
2022	632	5,090	$155,730
2023	552	4,313	$107,310
2024	592	5,460	$121,460

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	259	865	$30,463
2016	313	1,006	$24,782
2017	319	1,063	$23,444
2018	334	1,135	$29,334
2019	337	1,108	$24,136
2020	327	1,219	$23,191
2021	369	1,267	$50,785
2022	444	1,436	$70,740
2023	441	1,366	$111,742
2024	397	1,269	$112,978

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	19	$1,291
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92584	Test to assess electrical potentials generated in the inner ear as a result of sound stimulation	65	65	$74
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	165	165	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	223	289	$54
92557	Comprehensive hearing and speech recognition test	245	257	$23
92567	Test to assess middle ear function	238	252	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucala	Mepolizumab	23	644	$80,726
Azelastine Hcl	Azelastine Hcl	178	5,746	$4,823
Epinephrine	Epinephrine	14	179	$3,203
Montelukast Sodium	Montelukast Sodium	241	10,602	$2,726
Scopolamine	Scopolamine	12	336	$1,559

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$319	AERIN MEDICAL INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for George H. Godwin, M.D., F.A.C.S.?

Tedicare shows public-source Medicare data for George H. Godwin, M.D., F.A.C.S. (NPI 1558342931), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George H. Godwin, M.D., F.A.C.S. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George H. Godwin, M.D., F.A.C.S.?

George H. Godwin, M.D., F.A.C.S. is linked to DECATUR ENT ASSOCIATES P C (billing NPI 1164487708) in the available physician profile data.

Does George H. Godwin, M.D., F.A.C.S. have Open Payments data?

George H. Godwin, M.D., F.A.C.S. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.